ArticleMolecular therapy. Methods & clinical development2016

Construction of a hybrid β-hexosaminidase subunit capable of forming stable homodimers that hydrolyze GM2 ganglioside in vivo.

Michael B Tropak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.